好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Treatment with Resveratrol, trans-3,4[apos],5-trihydroxystilbene Polyphenol Decreases Amyloid Beta Precursor Protein (A[beta]PP), Amyloid-[beta] (A[beta]) Oligomerization and Myostatin in A[beta]PP-Overexpressing Cultured Human Muscle Fibers (A[beta]PP[sup]+[/sup]-CHMF[ndash]IBM Model): Relevance to Treatment of Sporadic-IBM Patients
Muscle Disease/Neuromuscular Junction
(-)
006
Authors/Disclosures
Anna Nogalska, PhD No disclosure on file
Carla D'Agostino, PhD (USC Neuromuscular Center) No disclosure on file
No disclosure on file
W. K. Engel, MD, FAAN No disclosure on file
Valerie Askanas, MD, PhD, FAAN (Professor Emeritus University of Southern California Keck School) No disclosure on file
George R. Wilmot, MD, PhD (Emory University Dept of Neurology) Dr. Wilmot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar Therapeutics. The institution of Dr. Wilmot has received research support from Friedrich Ataxia Research Alliance. The institution of Dr. Wilmot has received research support from National Ataxia Foundation. The institution of Dr. Wilmot has received research support from NIH. The institution of Dr. Wilmot has received research support from Reata. The institution of Dr. Wilmot has received research support from Biohaven Pharmaceuticals.